Bank of America’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-104,927
| Closed | -$349K | – | 7522 |
|
|
2019
Q4 | $349K | Buy |
104,927
+9,436
| +10% | +$30K | ﹤0.01% | 5262 |
|
|
2019
Q3 | $290K | Buy |
95,491
+40,059
| +72% | +$113K | ﹤0.01% | 5434 |
|
|
2019
Q2 | $132K | Buy |
55,432
+15,787
| +40% | +$47.2K | ﹤0.01% | 5849 |
|
|
2019
Q1 | $149K | Buy |
39,645
+28,730
| +263% | +$108K | ﹤0.01% | 5674 |
|
|
2018
Q4 | $39K | Sell |
10,915
-6,882
| -39% | -$29.9K | ﹤0.01% | 6301 |
|
|
2018
Q3 | $102K | Buy |
17,797
+13,886
| +355% | +$79.4K | ﹤0.01% | 5869 |
|
|
2018
Q2 | $20K | Sell |
3,911
-4,799
| -55% | -$24.7K | ﹤0.01% | 6512 |
|
|
2018
Q1 | $45K | Sell |
8,710
-10,917
| -56% | -$65.7K | ﹤0.01% | 6091 |
|
|
2017
Q4 | $118K | Buy |
19,627
+1,777
| +10% | +$10.7K | ﹤0.01% | 5675 |
|
|
2017
Q3 | $99K | Buy |
17,850
+7,734
| +76% | +$39.9K | ﹤0.01% | 5680 |
|
|
2017
Q2 | $47K | Buy |
10,116
+6,573
| +186% | +$29.3K | ﹤0.01% | 5903 |
|
|
2017
Q1 | $18K | Buy |
3,543
+25
| +0.7% | +$241 | ﹤0.01% | 6359 |
|
|
2016
Q4 | $39K | Buy |
3,518
+414
| +13% | +$3.9K | ﹤0.01% | 6047 |
|
|
2016
Q3 | $29K | Sell |
3,104
-9,277
| -75% | -$77.5K | ﹤0.01% | 5979 |
|
|
2016
Q2 | $79K | Buy |
+12,381
| New | +$82.2K | ﹤0.01% | 5649 |
|
|
2016
Q1 | – | Sell |
-5,452
| Closed | -$44K | – | 7496 |
|
|
2015
Q4 | $44K | Buy |
5,452
+5,372
| +6,715% | +$40.1K | ﹤0.01% | 6102 |
|
|
2015
Q3 | $1K | Sell |
80
-539
| -87% | -$5.49K | ﹤0.01% | 7087 |
|
|
2015
Q2 | $6K | Buy |
+619
| New | +$6.84K | ﹤0.01% | 6780 |
|
Bank of America's FOMX Position: Q1 2020 in Review
Bank of America sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 104,927 shares — an estimated $349K sold.
Bank of America first reported a position in FOMX in Q2 2015 and held it in 18 quarters. The position peaked at $349K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Bank of America reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 104,927 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $349K.
- Bank of America first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 18 quarters.
- Bank of America's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $349K in Q4 2019.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.